Skip to main content

Articles

425 result(s) for 'Breast expansion' within Breast Cancer Research

Page 8 of 9

  1. The local microenvironment influences tumor progression in several important ways. A recent study by Nguyen-Ngoc and colleagues used explants of primary human and mouse mammary tumors to examine how the compos...

    Authors: Veronica Calvo and Paraic A Kenny
    Citation: Breast Cancer Research 2013 15:301
  2. Most human mammary epithelial cells (HMEC) cultured from histologically normal breast tissues enter a senescent state termed stasis after 5 to 20 population doublings. These senescent cells display increased s...

    Authors: Rituparna Mukhopadhyay, Sylvain V Costes, Alexey V Bazarov, William C Hines, Mary Helen Barcellos-Hoff and Paul Yaswen
    Citation: Breast Cancer Research 2010 12:R11
  3. The human epidermal growth factor receptor 2 (HER2) represents one of the most studied tumor-associated antigens (TAAs) for cancer immunotherapy. The monoclonal antibody (mAb) trastuzumab has improved the outc...

    Authors: Meili Sun, Huan Shi, Chuanyong Liu, Jie Liu, Xianqiang Liu and Yuping Sun
    Citation: Breast Cancer Research 2014 16:R61
  4. The development and progression of estrogen receptor alpha positive (ERα+) breast cancer has been linked epidemiologically to prolactin. However, activation of the canonical mediator of prolactin, STAT5, is as...

    Authors: Craig E. Barcus, Kathleen A. O’Leary, Jennifer L. Brockman, Debra E. Rugowski, Yuming Liu, Nancy Garcia, Menggang Yu, Patricia J. Keely, Kevin W. Eliceiri and Linda A. Schuler
    Citation: Breast Cancer Research 2017 19:9
  5. In humans, an early full-term pregnancy reduces lifetime breast cancer risk by up to 50% whereas a later pregnancy (>35 years old) can increase lifetime risk. Several mechanisms have been suggested, including ...

    Authors: Kara L Britt, Howard Kendrick, Joseph L Regan, Gemma Molyneux, Fiona-Ann Magnay, Alan Ashworth and Matthew J Smalley
    Citation: Breast Cancer Research 2009 11:R20
  6. The functional unit of the mammary gland has been defined as the epithelial cell plus its microenvironment, a hypothesis that predicts changes in epithelial cell function will be accompanied by concurrent chan...

    Authors: Rhonda Hattar, Ori Maller, Shauntae McDaniel, Kirk C Hansen, Karla J Hedman, Traci R Lyons, Scott Lucia, R Storey Wilson Jr and Pepper Schedin
    Citation: Breast Cancer Research 2009 11:R5
  7. In utero endocrine disruption is linked to increased risk of breast cancer later in life. Despite numerous studies establishing this linkage, the long-term molecular changes that predispose mammary cells to ca...

    Authors: Clarissa Wormsbaecher, Andrea R. Hindman, Alex Avendano, Marcos Cortes-Medina, Caitlin E. Jones, Andrew Bushman, Lotanna Onua, Claire E. Kovalchin, Alina R. Murphy, Hannah L. Helber, Ali Shapiro, Kyle Voytovitch, Xingyan Kuang, Renan Aguilar-Valenzuela, Jennifer L. Leight, Jonathan W. Song…
    Citation: Breast Cancer Research 2020 22:41
  8. Solid tumors produce proteins that can induce the accumulation of bone marrow-derived cells in various tissues, and these cells can enhance metastatic tumor growth by several mechanisms. 4T1 murine mammary tum...

    Authors: Momir Bosiljcic, Rachel A. Cederberg, Melisa J. Hamilton, Nancy E. LePard, Bryant T. Harbourne, Jenna L. Collier, Elizabeth C. Halvorsen, Rocky Shi, S. Elizabeth Franks, Ada Y. Kim, Judit P. Banáth, Mark Hamer, Fabio M. Rossi and Kevin L. Bennewith
    Citation: Breast Cancer Research 2019 21:103
  9. Genomic regulatory networks specify how cellular gene expression responds to external temporal and spatial stimuli, ensuring that correct cell fate decisions are made and the appropriate cell phenotypes are ad...

    Authors: Matthew J Naylor and Christopher J Ormandy
    Citation: Breast Cancer Research 2007 9:302
  10. Lobular carcinoma in situ (LCIS) is considered to be a risk factor for the development of invasive breast carcinoma, but it may also be a non-obligate precursor to invasive lobular carcinoma (ILC). Many LCIS lesi...

    Authors: Greg J. Logan, David J. Dabbs, Peter C. Lucas, Rachel C. Jankowitz, Daniel D. Brown, Beth Z. Clark, Steffi Oesterreich and Priscilla F. McAuliffe
    Citation: Breast Cancer Research 2015 17:76
  11. Basal-like breast cancers (BLBCs) are a leading cause of cancer death due to their capacity to metastasize and lack of effective therapies. More than half of BLBCs have a dysfunctional BRCA1. Although most BRCA1-...

    Authors: Feng Bai, Shiqin Liu, Xiong Liu, Daniel P. Hollern, Alexandria Scott, Chuying Wang, Lihan Zhang, Cheng Fan, Li Fu, Charles M. Perou, Wei-Guo Zhu and Xin-Hai Pei
    Citation: Breast Cancer Research 2021 23:10
  12. The limited ability of current treatments to control metastasis and the proposed antitumor properties of specific nutrients prompted us to examine the effect of a specific formulation (nutrient supplement [NS]...

    Authors: M Waheed Roomi, Nusrath W Roomi, Vadim Ivanov, Tatiana Kalinovsky, Aleksandra Niedzwiecki and Matthias Rath
    Citation: Breast Cancer Research 2005 7:R291
  13. The neuron-glial antigen 2 (NG2) proteoglycan promotes pericyte recruitment and mediates pericyte interaction with endothelial cells. In the absence of NG2, blood vessel development is negatively impacted in s...

    Authors: Krissa Gibby, Weon-Kyoo You, Kuniko Kadoya, Hildur Helgadottir, Lawrence JT Young, Lesley G Ellies, Yunchao Chang, Robert D Cardiff and William B Stallcup
    Citation: Breast Cancer Research 2012 14:R67
  14. Periostin (Postn) is a secreted cell adhesion protein that activates signaling pathways to promote cancer cell survival, angiogenesis, invasion, and metastasis. Interestingly, Postn is frequently overexpressed...

    Authors: Roshan Sriram, Vivian Lo, Benjamin Pryce, Lilia Antonova, Alan J Mears, Manijeh Daneshmand, Bruce McKay, Simon J Conway, William J Muller and Luc A Sabourin
    Citation: Breast Cancer Research 2015 17:7
  15. The experiments reported here address the question of whether a short-term hormone treatment can prevent mammary tumorigenesis in two different genetically engineered mouse models.

    Authors: Lakshmanaswamy Rajkumar, Frances S Kittrell, Raphael C Guzman, Powel H Brown, Satyabrata Nandi and Daniel Medina
    Citation: Breast Cancer Research 2007 9:R12
  16. The mammary gland undergoes apoptosis when estrogen ablation occurs, either naturally or enforced. The gland is known to execute the apoptotic process post weaning. Although the involuting mammary gland displa...

    Authors: Reginald Halaby
    Citation: Breast Cancer Research 2001 1:4
  17. During pregnancy, as the mammary gland prepares for synthesis and delivery of milk to newborns, a luminal mammary epithelial cell (MEC) subpopulation proliferates rapidly in response to systemic hormonal cues ...

    Authors: Michelle M. Williams, David B. Vaught, Meghan Morrison Joly, Donna J. Hicks, Violeta Sanchez, Philip Owens, Bushra Rahman, David L. Elion, Justin M. Balko and Rebecca S. Cook
    Citation: Breast Cancer Research 2017 19:105
  18. High mammographic density has been correlated with a 4-fold to 6-fold increased risk of developing breast cancer, and is associated with increased stromal deposition of extracellular matrix proteins, including...

    Authors: María G. García-Mendoza, David R. Inman, Suzanne M. Ponik, Justin J. Jeffery, Dagna S. Sheerar, Rachel R. Van Doorn and Patricia J. Keely
    Citation: Breast Cancer Research 2016 18:49
  19. The Rho GTPase Cdc42 is overexpressed and hyperactivated in breast tumors compared to normal breast tissue. Cdc42 regulates key processes that are critical for mammary gland morphogenesis and become disrupted ...

    Authors: Kristi Bray, Melissa Gillette, Jeanette Young, Elizabeth Loughran, Melissa Hwang, James Cooper Sears and Tracy Vargo-Gogola
    Citation: Breast Cancer Research 2013 15:R91
  20. The adult mammary epithelium is composed of basal and luminal cells. The luminal lineage comprises two major cell populations, positive and negative for estrogen and progesterone receptors (ER and PR, respecti...

    Authors: Aurélie Chiche, Amandine Di-Cicco, Laura Sesma-Sanz, Laura Bresson, Pierre de la Grange, Marina A. Glukhova, Marisa M. Faraldo and Marie-Ange Deugnier
    Citation: Breast Cancer Research 2019 21:13
  21. Early stopping of clinical trials in favour of a new treatment creates ethical and scientific difficulties, which are different from those associated with early stopping due to toxicity or futility. Two major ...

    Authors: Jack Cuzick, Anthony Howell and John Forbes
    Citation: Breast Cancer Research 2005 7:181
  22. During pregnancy the mammary epithelial compartment undergoes extreme proliferation and differentiation, facilitated by stem/progenitor cells. Mouse mammary epithelium in nonpregnant mice contains long label-r...

    Authors: Brian W Booth, Corinne A Boulanger and Gilbert H Smith
    Citation: Breast Cancer Research 2008 10:R90
  23. Breast cancer exhibits significant molecular, histological, and pathological diversity. Factors that impact this heterogeneity are poorly understood; however, transformation of distinct normal cell populations...

    Authors: Daria Drobysheva, Brittni Alise Smith, Maria McDowell, Katrin P. Guillen, Huseyin Atakan Ekiz and Bryan E. Welm
    Citation: Breast Cancer Research 2015 17:132
  24. Human Epidermal Growth Factor Receptor (ERBB4/HER4) belongs to the Epidermal Growth Factor receptor/ERBB family of receptor tyrosine kinases. While ERBB1, ERBB2 and ERBB3 are often overexpressed or activated i...

    Authors: Vikram B Wali, Maureen Gilmore-Hebert, Ramanaiah Mamillapalli, Jonathan W Haskins, Kari J Kurppa, Klaus Elenius, Carmen J Booth and David F Stern
    Citation: Breast Cancer Research 2014 16:501
  25. Our previous studies detected focal disruptions in myoepithelial cell layers of several ducts with carcinoma in situ. The cell cluster overlying each of the myoepithelial disruptions showed a marked reduction in ...

    Authors: Yan-gao Man, Lisa Tai, Ross Barner, Russell Vang, Jeffrey S Saenger, Kris M Shekitka, Gary L Bratthauer, Darren T Wheeler, Chang Y Liang, Tuyethoa N Vinh and Brian L Strauss
    Citation: Breast Cancer Research 2003 5:R231
  26. Early pregnancy has a strong protective effect against breast cancer in humans and rodents, but the underlying mechanism is unknown. Because breast cancers are thought to arise from specific cell subpopulation...

    Authors: Fabienne Meier-Abt, Emanuela Milani, Tim Roloff, Heike Brinkhaus, Stephan Duss, Dominique S Meyer, Ina Klebba, Piotr J Balwierz, Erik van Nimwegen and Mohamed Bentires-Alj
    Citation: Breast Cancer Research 2013 15:R36
  27. Puberty is a period of increased susceptibility to factors that cause increased breast cancer risk in adulthood. Mammary end buds (EBs) that develop during puberty are believed to be the targets of breast canc...

    Authors: Mark D Aupperlee, Jeffrey R Leipprandt, Jessica M Bennett, Richard C Schwartz and Sandra Z Haslam
    Citation: Breast Cancer Research 2013 15:R44
  28. Massive tissue remodelling occurs within the mammary gland during pregnancy, resulting in the formation of lobuloalveoli that are capable of milk secretion. Endocrine signals generated predominantly by prolact...

    Authors: Samantha R Oakes, Heidi N Hilton and Christopher J Ormandy
    Citation: Breast Cancer Research 2006 8:207
  29. Lobular carcinoma in situ (LCIS) is a non-invasive breast lesion that is typically found incidentally on biopsy and is often associated with invasive lobular carcinoma (ILC). LCIS is considered by some to be a ri...

    Authors: Vandna Shah, Salpie Nowinski, Dina Levi, Irek Shinomiya, Narda Kebaier Ep Chaabouni, Cheryl Gillett, Anita Grigoriadis, Trevor A. Graham, Rebecca Roylance, Michael A. Simpson, Sarah E. Pinder and Elinor J. Sawyer
    Citation: Breast Cancer Research 2017 19:7
  30. Retinoic acid signaling pathways are disabled in human breast cancer suggesting a controlling role in normal mammary growth that might be lost in tumorigenesis. We tested a single receptor isotype, RARα1 (reti...

    Authors: Ellen Cohn, Liliana Ossowski, Silvina Bertran, Christine Marzan and Eduardo F Farias
    Citation: Breast Cancer Research 2010 12:R79
  31. Molecular dissection of the signaling pathways that underlie complex biological responses in the mammary epithelium is limited by the difficulty of propagating large numbers of mouse mammary epithelial cells, ...

    Authors: Ethan A Kohn, Zhijun Du, Misako Sato, Catherine MH Van Schyndle, Michael A Welsh, Yu-an Yang, Christina H Stuelten, Binwu Tang, Wenjun Ju, Erwin P Bottinger and Lalage M Wakefield
    Citation: Breast Cancer Research 2010 12:R83
  32. Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors have been established as a standard treatment for hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast ca...

    Authors: Chang Gon Kim, Min Hwan Kim, Jee Hung Kim, Seul-Gi Kim, Gun Min Kim, Tae Yeong Kim, Won-Ji Ryu, Jee Ye Kim, Hyung Seok Park, Seho Park, Young Up Cho, Byeong Woo Park, Seung Il Kim, Joon Jeong and Joohyuk Sohn
    Citation: Breast Cancer Research 2023 25:4
  33. Activation of focal adhesion kinase (FAK) is hypothesized to play an important role in the pathogenesis of human breast cancer.

    Authors: Hicham Lahlou, Virginie Sanguin-Gendreau, Margaret C Frame and William J Muller
    Citation: Breast Cancer Research 2012 14:R36
  34. The molecular circuitry of different cell types dictates their normal function as well as their response to oncogene activation. For instance, mice lacking the Wip1 phosphatase (also known as PPM1D; protein ph...

    Authors: Gerard A Tarulli, Duvini De Silva, Victor Ho, Kamini Kunasegaran, Kakaly Ghosh, Bryan C Tan, Dmitry V Bulavin and Alexandra M Pietersen
    Citation: Breast Cancer Research 2013 15:R10
  35. Differentiation of stem cells into highly specialised cells requires gene expression changes brought about by remodelling of the chromatin architecture. During this lineage-commitment process, the majority of ...

    Authors: Holly Holliday, Laura A. Baker, Simon R. Junankar, Susan J. Clark and Alexander Swarbrick
    Citation: Breast Cancer Research 2018 20:100
  36. The developmental preparation of the mammary gland for milk production that occurs during pregnancy is followed by an equally dramatic process of involution as the gland returns to its prepregnancy state. Two ...

    Authors: Stephen R Master and Lewis A Chodosh
    Citation: Breast Cancer Research 2004 6:89
  37. A challenge in human mammary epithelial cell (HMEC) culture is sustaining the representation of competing luminal, myoepithelial, and progenitor lineages over time. As cells replicate in culture, myoepithelial...

    Authors: Michael E. Todhunter, Masaru Miyano, Eric G. Carlson, Stefan Hinz and Mark A. LaBarge
    Citation: Breast Cancer Research 2023 25:6
  38. Estrogen promotes breast cancer development and progression mainly through estrogen receptor (ER). However, blockage of estrogen production or action prevents development of and suppresses progression of ER-ne...

    Authors: Chuying Wang, Feng Bai, Li-han Zhang, Alexandria Scott, Enxiao Li and Xin-Hai Pei
    Citation: Breast Cancer Research 2018 20:74
  39. Cancer vaccines have the potential to induce curative anti-tumor immune responses and better adjuvants may improve vaccine efficacy. We have previously shown that Hp91, a peptide derived from the B box domain ...

    Authors: Diahnn F Campbell, Rebecca Saenz, Ila S Bharati, Daniel Seible, Liangfang Zhang, Sadik Esener, Bradley Messmer, Marie Larsson and Davorka Messmer
    Citation: Breast Cancer Research 2015 17:48

Annual Journal Metrics

  • 2022 Citation Impact
    7.4 - 2-year Impact Factor
    7.4 - 5-year Impact Factor
    1.764 - SNIP (Source Normalized Impact per Paper)
    2.408 - SJR (SCImago Journal Rank)

    2023 Speed
    20 days submission to first editorial decision for all manuscripts (Median)
    129 days submission to accept (Median)

    2023 Usage 
    2,432,781 downloads
    1,561 Altmetric mentions